UBS Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Sell |
440,432
-29,050
| -6% | -$1.06M | ﹤0.01% | 2048 |
|
|
2025
Q1 | $17M | Buy |
469,482
+143,831
| +44% | +$5.21M | ﹤0.01% | 1929 |
|
|
2024
Q4 | $13.7M | Buy |
325,651
+232,582
| +250% | +$9.78M | ﹤0.01% | 2078 |
|
|
2024
Q3 | $5.17M | Sell |
93,069
-102,822
| -52% | -$5.71M | ﹤0.01% | 2233 |
|
|
2024
Q2 | $8.05M | Buy |
195,891
+26,728
| +16% | +$1.1M | ﹤0.01% | 1762 |
|
|
2024
Q1 | $7.9M | Buy |
169,163
+111,342
| +193% | +$5.2M | ﹤0.01% | 1785 |
|
|
2023
Q4 | $2.77M | Buy |
57,821
+11,429
| +25% | +$547K | ﹤0.01% | 2554 |
|
|
2023
Q3 | $1.65M | Sell |
46,392
-17,078
| -27% | -$609K | ﹤0.01% | 2699 |
|
|
2023
Q2 | $2.93M | Sell |
63,470
-11,510
| -15% | -$531K | ﹤0.01% | 2352 |
|
|
2023
Q1 | $3.01M | Sell |
74,980
-90,118
| -55% | -$3.61M | ﹤0.01% | 2235 |
|
|
2022
Q4 | $7.65M | Buy |
165,098
+135,455
| +457% | +$6.28M | ﹤0.01% | 1522 |
|
|
2022
Q3 | $1.23M | Sell |
29,643
-17,506
| -37% | -$725K | ﹤0.01% | 2708 |
|
|
2022
Q2 | $2.81M | Sell |
47,149
-45,188
| -49% | -$2.7M | ﹤0.01% | 2159 |
|
|
2022
Q1 | $6.71M | Buy |
92,337
+28,959
| +46% | +$2.1M | ﹤0.01% | 1711 |
|
|
2021
Q4 | $5.33M | Buy |
63,378
+7,193
| +13% | +$605K | ﹤0.01% | 2037 |
|
|
2021
Q3 | $5.07M | Buy |
56,185
+30,559
| +119% | +$2.76M | ﹤0.01% | 1994 |
|
|
2021
Q2 | $2.44M | Sell |
25,626
-24,003
| -48% | -$2.29M | ﹤0.01% | 2583 |
|
|
2021
Q1 | $5.65M | Buy |
49,629
+22,002
| +80% | +$2.51M | ﹤0.01% | 1851 |
|
|
2020
Q4 | $3.83M | Buy |
27,627
+1,470
| +6% | +$204K | ﹤0.01% | 2075 |
|
|
2020
Q3 | $2.15M | Sell |
26,157
-5,562
| -18% | -$457K | ﹤0.01% | 2349 |
|
|
2020
Q2 | $2.48M | Sell |
31,719
-99,111
| -76% | -$7.76M | ﹤0.01% | 2117 |
|
|
2020
Q1 | $5.81M | Buy |
130,830
+48,730
| +59% | +$2.17M | ﹤0.01% | 1407 |
|
|
2019
Q4 | $3.51M | Sell |
82,100
-82,148
| -50% | -$3.51M | ﹤0.01% | 2282 |
|
|
2019
Q3 | $7.03M | Buy |
164,248
+124,167
| +310% | +$5.31M | ﹤0.01% | 1612 |
|
|
2019
Q2 | $2.55M | Buy |
40,081
+11,717
| +41% | +$744K | ﹤0.01% | 2329 |
|
|
2019
Q1 | $1.97M | Sell |
28,364
-121,450
| -81% | -$8.42M | ﹤0.01% | 2439 |
|
|
2018
Q4 | $6.51M | Buy |
149,814
+108,380
| +262% | +$4.71M | ﹤0.01% | 1518 |
|
|
2018
Q3 | $3.16M | Buy |
41,434
+13,200
| +47% | +$1.01M | ﹤0.01% | 2245 |
|
|
2018
Q2 | $2.17M | Sell |
28,234
-85,918
| -75% | -$6.6M | ﹤0.01% | 2482 |
|
|
2018
Q1 | $5.82M | Buy |
114,152
+90,294
| +378% | +$4.6M | ﹤0.01% | 1731 |
|
|
2017
Q4 | $1.11M | Sell |
23,858
-11,562
| -33% | -$536K | ﹤0.01% | 2953 |
|
|
2017
Q3 | $1.89M | Buy |
35,420
+18,098
| +104% | +$964K | ﹤0.01% | 2538 |
|
|
2017
Q2 | $1.08M | Buy |
17,322
+7,608
| +78% | +$472K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $658K | Sell |
9,714
-36,956
| -79% | -$2.5M | ﹤0.01% | 3114 |
|
|
2016
Q4 | $3.28M | Buy |
46,670
+16,636
| +55% | +$1.17M | ﹤0.01% | 1898 |
|
|
2016
Q3 | $2.13M | Buy |
30,034
+3,120
| +12% | +$221K | ﹤0.01% | 2172 |
|
|
2016
Q2 | $1.32M | Buy |
26,914
+13,633
| +103% | +$667K | ﹤0.01% | 2512 |
|
|
2016
Q1 | $841K | Sell |
13,281
-3,845
| -22% | -$243K | ﹤0.01% | 2783 |
|
|
2015
Q4 | $1.92M | Buy |
17,126
+6,989
| +69% | +$784K | ﹤0.01% | 2212 |
|
|
2015
Q3 | $977K | Sell |
10,137
-18,425
| -65% | -$1.78M | ﹤0.01% | 2660 |
|
|
2015
Q2 | $2.93M | Buy |
28,562
+18,807
| +193% | +$1.93M | ﹤0.01% | 2020 |
|
|
2015
Q1 | $606K | Buy |
9,755
+203
| +2% | +$12.6K | ﹤0.01% | 3102 |
|
|
2014
Q4 | $419K | Buy |
+9,552
| New | +$419K | ﹤0.01% | 3307 |
|